Comparison Overview

Bako Diagnostics

VS

King Faisal Specialist Hospital and Research Center

Bako Diagnostics

6240 Shiloh Rd, None, Alpharetta, GA, US, 30005
Last Update: 2025-12-01
Between 700 and 749

Bako Diagnostics is a provider of diagnostic and therapeutic services with a unique focus on pathology of the lower extremity. Bako’s comprehensive testing menu includes ENFD Analysis, Mass Spectrometry, for rapid identification of bacteria from culture specimens, and Molecular Genetics for the detection of micro-organisms and as a diagnostic aid in certain pathologic diagnoses. Bako’s in-network services are available through its more than 200 million covered lives, including all five national health plans and fully compliant patient-friendly billing policies. Over the past nine years, Bako has evolved into one of the podiatric profession’s principal sources of educational sponsorship. Bako Diagnostics, your professional partner for disease diagnostics and management! For more information, call us at 855-422-5628 or visit bakodx.com.

NAICS: 62
NAICS Definition: Health Care and Social Assistance
Employees: 199
Subsidiaries: 1
12-month incidents
0
Known data breaches
2
Attack type number
1

King Faisal Specialist Hospital and Research Center

At Takhassusi, Al Madhar Ash Shamali, Riyadh, 11211, SA
Last Update: 2025-12-01
Between 750 and 799

King Faisal Specialist Hospital and Research Centre (KFSH&RC) is a 2415 -bed tertiary/quaternary care hospital with facilities in Riyadh, Jeddah & Madinah in the Kingdom of Saudi Arabia. offering Established in 1970 on land donated by the late King Faisal Bin Abdulaziz, in the capital city of Riyadh and officially opened in April 1975 by King Khalid Bin Abdulaziz with a current total land area of 921,000 square meters KFSH&RC employs over 16,000 employees from over 63 different nationalities Highly specialized in inpatient and outpatient medical care, KFSH&RC participates in many clinical and research studies; it is consistently recognized and ranked as one of the nation's top hospital specializing in Oncology, Organ Transplantation, Cardiovascular Diseases Neurosciences and Genetic Diseases. King Faisal Specialist Hospital and Research Centre provides the level of specialized health care in an robust and striving educational and research environment. KFSH&RC is accredited by the Joint Commission International (JCI) and is proud to be one of only six hospitals outside of the USA to have achieved Magnet Hospital status awarded by the American Nurses Credentialing Centre (ANCC) and more recently, KFSH&RC was the first hospital outside of Northern America to be awarded Stage 7 HIMSS Electronic Medical Records, the highest level of using Electronic Health Records

NAICS: 62
NAICS Definition: Health Care and Social Assistance
Employees: 13,703
Subsidiaries: 1
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/bakodiagnostics.jpeg
Bako Diagnostics
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/kfshrc.jpeg
King Faisal Specialist Hospital and Research Center
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
Bako Diagnostics
100%
Compliance Rate
0/4 Standards Verified
King Faisal Specialist Hospital and Research Center
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Hospitals and Health Care Industry Average (This Year)

No incidents recorded for Bako Diagnostics in 2025.

Incidents vs Hospitals and Health Care Industry Average (This Year)

No incidents recorded for King Faisal Specialist Hospital and Research Center in 2025.

Incident History — Bako Diagnostics (X = Date, Y = Severity)

Bako Diagnostics cyber incidents detection timeline including parent company and subsidiaries

Incident History — King Faisal Specialist Hospital and Research Center (X = Date, Y = Severity)

King Faisal Specialist Hospital and Research Center cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/bakodiagnostics.jpeg
Bako Diagnostics
Incidents

Date Detected: 12/2021
Type:Breach
Blog: Blog

Date Detected: 12/2021
Type:Breach
Blog: Blog
https://images.rankiteo.com/companyimages/kfshrc.jpeg
King Faisal Specialist Hospital and Research Center
Incidents

No Incident

FAQ

King Faisal Specialist Hospital and Research Center company demonstrates a stronger AI Cybersecurity Score compared to Bako Diagnostics company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

Bako Diagnostics company has historically faced a number of disclosed cyber incidents, whereas King Faisal Specialist Hospital and Research Center company has not reported any.

In the current year, King Faisal Specialist Hospital and Research Center company and Bako Diagnostics company have not reported any cyber incidents.

Neither King Faisal Specialist Hospital and Research Center company nor Bako Diagnostics company has reported experiencing a ransomware attack publicly.

Bako Diagnostics company has disclosed at least one data breach, while the other King Faisal Specialist Hospital and Research Center company has not reported such incidents publicly.

Neither King Faisal Specialist Hospital and Research Center company nor Bako Diagnostics company has reported experiencing targeted cyberattacks publicly.

Neither Bako Diagnostics company nor King Faisal Specialist Hospital and Research Center company has reported experiencing or disclosing vulnerabilities publicly.

Neither Bako Diagnostics nor King Faisal Specialist Hospital and Research Center holds any compliance certifications.

Neither company holds any compliance certifications.

Both King Faisal Specialist Hospital and Research Center company and Bako Diagnostics company have a similar number of subsidiaries worldwide.

King Faisal Specialist Hospital and Research Center company employs more people globally than Bako Diagnostics company, reflecting its scale as a Hospitals and Health Care.

Neither Bako Diagnostics nor King Faisal Specialist Hospital and Research Center holds SOC 2 Type 1 certification.

Neither Bako Diagnostics nor King Faisal Specialist Hospital and Research Center holds SOC 2 Type 2 certification.

Neither Bako Diagnostics nor King Faisal Specialist Hospital and Research Center holds ISO 27001 certification.

Neither Bako Diagnostics nor King Faisal Specialist Hospital and Research Center holds PCI DSS certification.

Neither Bako Diagnostics nor King Faisal Specialist Hospital and Research Center holds HIPAA certification.

Neither Bako Diagnostics nor King Faisal Specialist Hospital and Research Center holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

HedgeDoc is an open source, real-time, collaborative, markdown notes application. Prior to 1.10.4, some of HedgeDoc's OAuth2 endpoints for social login providers such as Google, GitHub, GitLab, Facebook or Dropbox lack CSRF protection, since they don't send a state parameter and verify the response using this parameter. This vulnerability is fixed in 1.10.4.

Risk Information
cvss3
Base: 3.7
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:R/S:U/C:L/I:L/A:N
Description

Langflow versions up to and including 1.6.9 contain a chained vulnerability that enables account takeover and remote code execution. An overly permissive CORS configuration (allow_origins='*' with allow_credentials=True) combined with a refresh token cookie configured as SameSite=None allows a malicious webpage to perform cross-origin requests that include credentials and successfully call the refresh endpoint. An attacker-controlled origin can therefore obtain fresh access_token / refresh_token pairs for a victim session. Obtained tokens permit access to authenticated endpoints — including built-in code-execution functionality — allowing the attacker to execute arbitrary code and achieve full system compromise.

Risk Information
cvss4
Base: 9.4
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

A vulnerability was detected in xerrors Yuxi-Know up to 0.4.0. This vulnerability affects the function OtherEmbedding.aencode of the file /src/models/embed.py. Performing manipulation of the argument health_url results in server-side request forgery. The attack can be initiated remotely. The exploit is now public and may be used. The patch is named 0ff771dc1933d5a6b78f804115e78a7d8625c3f3. To fix this issue, it is recommended to deploy a patch. The vendor responded with a vulnerability confirmation and a list of security measures they have established already (e.g. disabled URL parsing, disabled URL upload mode, removed URL-to-markdown conversion).

Risk Information
cvss2
Base: 5.8
Severity: LOW
AV:N/AC:L/Au:M/C:P/I:P/A:P
cvss3
Base: 4.7
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:L/I:L/A:L
cvss4
Base: 5.1
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

A security vulnerability has been detected in Rarlab RAR App up to 7.11 Build 127 on Android. This affects an unknown part of the component com.rarlab.rar. Such manipulation leads to path traversal. It is possible to launch the attack remotely. Attacks of this nature are highly complex. It is indicated that the exploitability is difficult. The exploit has been disclosed publicly and may be used. Upgrading to version 7.20 build 128 is able to mitigate this issue. You should upgrade the affected component. The vendor responded very professional: "This is the real vulnerability affecting RAR for Android only. WinRAR and Unix RAR versions are not affected. We already fixed it in RAR for Android 7.20 build 128 and we publicly mentioned it in that version changelog. (...) To avoid confusion among users, it would be useful if such disclosure emphasizes that it is RAR for Android only issue and WinRAR isn't affected."

Risk Information
cvss2
Base: 5.1
Severity: HIGH
AV:N/AC:H/Au:N/C:P/I:P/A:P
cvss3
Base: 5.0
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:R/S:U/C:L/I:L/A:L
cvss4
Base: 2.3
Severity: HIGH
CVSS:4.0/AV:N/AC:H/AT:N/PR:N/UI:P/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

A weakness has been identified in ZSPACE Q2C NAS up to 1.1.0210050. Affected by this issue is the function zfilev2_api.OpenSafe of the file /v2/file/safe/open of the component HTTP POST Request Handler. This manipulation of the argument safe_dir causes command injection. It is possible to initiate the attack remotely. The exploit has been made available to the public and could be exploited. The vendor was contacted early about this disclosure but did not respond in any way.

Risk Information
cvss2
Base: 9.0
Severity: LOW
AV:N/AC:L/Au:S/C:C/I:C/A:C
cvss3
Base: 8.8
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
cvss4
Base: 7.4
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X